Abstract
Tissue microarray (TMA) technology is a robust “high throughput” method of tissue analysis, whereby a large number of patient samples can be examined in a short time using a minimum number of slides. In a TMA, cylinders of tissue are cored out of formalin-fixed, paraffin-embedded tissue blocks and slotted in a regular grid pattern into a blank recipient paraffin wax block. The TMA block is then cut using a standard laboratory microtome. Sections generated are suitable for all in situ techniques, such as immunohistochemistry (IHC) and in situ hybridisation, using essentially the same protocols as are used in conventional sections. The principle advantages of TMAs are that they save valuable biological material and ensure more reproducible reaction conditions while at the same time reducing re-agent costs and laboratory processing. Immunohistochemical studies designed to examine the prognostic utility of TMAs compared with large sections have generally found that they are comparable.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gulmann, C., Loring, P., O’Grady, A., and Kay, E. (2004) Miniature tissue microarrays for HercepTest standardisation and analysis. J Clin Path 57, 1229–1231.
Nielsen, T.O., Hsu, F.D., Jensen, K., Cheang, M., Karaca, G., Hu, Z., et al. (2004) Immunohistochemical and clinical characterisation of the basal-like subtype of invasive breast carcinoma. Clin Ca Res 10, 5367–5374.
Deutsch, E.W., Ball, C.A., Bova, G.S., Brazma, A., Bumgarner R.E., Campbell, D., et al. (2006) Development of the minimum information specification for in situ hybridization and immunohistochemistry experiments (MISFISHIE). OMICS 10, 205–208.
Camp, R.L., Chung, G.G., and Rimm, D.L. (2002) Automated subcellular localization and quantification of protein expression in tissue microarrays. Nature Medicine 8, 1323–1328.
Jhavar, S., Corbishley, C.M., Dearnaley, D., Fisher, C., Falconer, A., Parker, C., et al. (2004) Construction of tissue microarrays from prostate needle biopsy specimens. Br J Cancer 93, 478–482.
Yang, X.R., Charette, L.A., Garcia-Closas, M, Lissowska, J., Paal, E., Sidawy, M., et al. (2006) Construction and validation of tissue microarrays of ductal carcinoma in situ and terminal duct lobular units associated with invasive breast carcinoma. Diagn Mol Pathol 15, 157–162.
DiVito, K.A., Berger, A.J., Camp, R.L., Dolled-Filhart, M., Rimm, D.L., and Kluger, H.M. (2004) Automated quantitative analysis of tissue microarrays reveals an association between high Bcl-2 expression and improved outcome in melanoma. Cancer Res 64, 8773–8777.
Aubele, M., Mattis, A., Zitzelsberger, H., Walck, A., Kremer, M., Hutzler, P., et al. (1999) Intratumoral heterogeneity in breast carcinoma revealed by laser-microdissection and comparative genomic hybridisation. Cancer Genet Cytogenet 110, 94–102.
Trudel, M., Mulligan, L., Cavenee, W., Margolese, R., Cote, J., and Gariepy, G. (1992) Retinoblastoma and p53 gene product expression in breast carcinoma. Hum Pathol 23, 1388–1394.
Quirke, P., Dyson, J.E.D., Dixon, M.F., Bird, C.C., and Joslin, C.A.F. (1985) Heterogeneity of colorectal adenocarcinomas evaluated by flow cytometry and histopathology. Br J Cancer 51, 99–106.
Losi, L., Baisse, B., Bouzourene, H., and Benhattar, J. (2005) Evolution of intratumoral genetic heterogeneity during colorectal cancer progression. Carcinogenesis 26, 916–922.
Samowitz, W.S., and Slattery, M.L. (1999) Regional reproducibility of microsatellite instability in sporadic colorectal cancer. Genes Chromosomes Cancer 26, 106–114.
Torhorst, J., Bucher, C., Kononen, J., Haas, P., Zuber, M., Kochli, O.R., et al. (2001) Tissue microarrays for rapid linking of molecular changes to clinical endpoints. Am J Pathol 159, 2249–2256.
Aaltonen, K., Ahlin, C., Amini, R.M., Salonen, L., Fjallskog, M.L., Heikkila, P., et al. (2006) Reliability of cyclin A assessment on tissue microarrays in breast cancer compared to conventional histological slides. Br J Cancer 94, 1697–1702.
Bhargava, R., Gerald, W.L., Li, A.R., Pan, Q., Lal, P., Ladanyi, M., et al. (2005) EGFR gene amplification in breast cancer: correlation with epidermal growth factor receptor mRNA and protein expression and HER-2 status and absence of EGFR-activating mutations. Mod Pathol 18, 1027–1033.
Loring, P., Cummins, R., O’Grady, A., Kay, E.W. (2005) HER2 positivity in breast carcinoma: a comparison of chromogenic in situ hybridisation with fluorescent in situ hybridisation in tissue microarrays, with targeted evaluation of intratumoural heterogeneity by in situ hybridisation. Appl Immunohistochem Mol Morphol 13, 194–200.
Kay, E., O’Grady, A., Morgan, J.M., Wozniak, S., and Jasani, B. (2004) Use of tissue microarray for interlaboratory validation of HER2 immunocytochemical and FISH testing. J Clin Pathol 57, 1140–1144.
Press, M.F., Slamon, D.J., Flom, K.J., Park, J., Zhou, J.Y., and Bernstein, L. (2002) Evaluation of HER-2/neu gene amplification and overexpression: comparison of frequently used assay methods in a molecularly characterized cohort of breast cancer specimens. J Clin Onco 20, 3095–3105.
Ricardo, S., Milanezi, F., Carvalho, S., Leitao, D., and Schmitt, F. (2006) HER2 evaluation through the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomas. J Clin Pathol 60(9), 1001–1005.
Sapino, A., Marchio, C., Senetta, R., Castellano, I., Macri, L., Cassoni, P., et al. (2006) Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure. Virchows Arch 449, 288–296.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this protocol
Cite this protocol
Chandler, I., Houlston, R., Landberg, G. (2011). A Practical Guide to Constructing and Using Tissue Microarrays. In: Dillner, J. (eds) Methods in Biobanking. Methods in Molecular Biology, vol 675. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59745-423-0_22
Download citation
DOI: https://doi.org/10.1007/978-1-59745-423-0_22
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-58829-995-6
Online ISBN: 978-1-59745-423-0
eBook Packages: Springer Protocols